← All sarcoma trials
Recruiting now—Ages 18 Years and up

Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology

Sponsor: Universitaire Ziekenhuizen KU Leuven · NCT04990076 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Myoma;UterusSarcoma Uterus

What it tests

  • Hysterectomyprocedure

Where it's running1 site

1 international site

  • UZ Leuven

    Leuven, Belgium 300

    Recruiting now
    • Christine De Bruyn, MD(contact)+32 16 345125[email protected]
    • Dirk Timmerman, MD, PhD(principal investigator)
    • Thierry Van den Bosch, MD, PhD(sub investigator)
    • Ben Van Calster, MD, PhD(sub investigator)
    • Christine De Bruyn, MD(sub investigator)
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

Consecutive patients planned to undergo hysterectomy for myometrial pathology of more then 1cm (e.g. fibroid, focal adenomyosis, uterine sarcoma).

Exclusion Criteria:

* Patient's refusal
* Age \< 18 years
* Polymyomatous uterus
* Myometrial lesion with a diameter less then 10mm
* Patients currently treated for another cancer
* Patients with ovarian pathology, endometrial pathology of cervical pathology
* Power morcellation

Updated 2024-07-03 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.